Sarathal et al. reported that RSG alone and when co-encapsulated as a nanoformulation upregulated CREB, BDNF, nerve growth factor (NGF) and glial cell-derived neurotrophic factor (GDNF) expression in both in vitro and in vivo mouse models of AD [12,25,26]. This evidence concerns the gene BDNF and Alzheimer disease.